Gut microbiota, diet, and obesity-related disorders—The good, the bad, and the future challenges

Molecular Nutrition and Food Research

Volumn 61, Issue 1, 2017, Pages

  Portune, Kevin J ^a   Benítez Páez, Alfonso ^a   Del Pulgar, Eva Maria Gomez ^a   Cerrudo, Victor ^a   Sanz, Yolanda ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Diet; Metabolic health; Microbiota; Obesity

Indexed keywords

BILE ACID; FAT INTAKE; PROTEIN INTAKE;

BACTERIUM; DIET; DIET THERAPY; DIETARY FIBER; FAT INTAKE; FERMENTATION; HUMAN; INFLAMMATION; INTESTINE FLORA; LIPID DIET; METABOLISM; MICROBIOLOGY; OBESITY; PHARMACOLOGY; PROTEIN INTAKE; WHOLE GRAIN;

BACTERIA; BILE ACIDS AND SALTS; DIET; DIET, HIGH-FAT; DIETARY FATS; DIETARY FIBER; DIETARY PROTEINS; FERMENTATION; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; OBESITY; WHOLE GRAINS;

EID: 85007557370     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600252     Document Type: Review

References (144)

1. Tremaroli, V., Backhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489, 242–249.
2. Sommer, F., Backhed, F., The gut microbiota–masters of host development and physiology. Nat. Rev. Microbiol. 2013, 11, 227–238.
3. Flint, H. J., Scott, K. P., Louis, P., Duncan, S. H., The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 577–589.
4. Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. et al., The gut microbiota and host health: a new clinical frontier. Gut 2016, 65, 330–339.
5. Round, J. L., Mazmanian, S. K., The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9, 313–323.
6. Conlon, M. A., Bird, A. R., The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2015, 7, 17–44.
7. Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M. et al., Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5, 220–230.
8. Faith, J. J., Guruge, J. L., Charbonneau, M., Subramanian, S. et al., The long-term stability of the human gut microbiota. Science 2013, 341, 1237439.
9. David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B. et al., Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559–563.
10. Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K. et al., Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334, 105–108.
11. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M. et al., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U S A 2010, 107, 14691–14696.
12. Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I. et al., Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227.
13. Scott, K. P., Gratz, S. W., Sheridan, P. O., Flint, H. J. et al., The influence of diet on the gut microbiota. Pharmacol. Res. 2013, 69, 52–60.
14. Zhang, C., Zhang, M., Pang, X., Zhao, Y. et al., Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012, 6, 1848–1857.
15. Sonnenburg, E. D., Smits, S. A., Tikhonov, M., Higginbottom, S. K. et al., Diet-induced extinctions in the gut microbiota compound over generations. Nature 2016, 529, 212–215.
16. Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M. et al., The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 2012, 6, 1415–1426.
17. Evans, D. F., Pye, G., Bramley, R., Clark, A. G. et al., Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988, 29, 1035–1041.
18. Walker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W. et al., pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 2005, 71, 3692–3700.
19. Haro, C., Montes-Borrego, M., Rangel-Zuniga, O. A., Alcala-Diaz, J. F. et al., Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J. Clin. Endocrinol. Metab. 2016, 101, 233–242.
20. Jenkins, T. C., Wallace, R. J., Moate, P. J., Mosley, E. E., Board-invited review: recent advances in biohydrogenation of unsaturated fatty acids within the rumen microbial ecosystem. J. Anim. Sci. 2008, 86, 397–412.
21. Devillard, E., McIntosh, F. M., Duncan, S. H., Wallace, R. J., Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid. J. Bacteriol. 2007, 189, 2566–2570.
22. Druart, C., Bindels, L. B., Schmaltz, R., Neyrinck, A. M. et al., Ability of the gut microbiota to produce PUFA-derived bacterial metabolites: proof of concept in germ-free versus conventionalized mice. Mol. Nutr. Food Res. 2015, 59, 1603–1613.
23. Kishino, S., Takeuchi, M., Park, S. B., Hirata, A. et al., Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc. Natl. Acad. Sci. U S A 2013, 110, 17808–17813.
24. Gupta, R., Gupta, N., Rathi, P., Bacterial lipases: an overview of production, purification and biochemical properties. Appl. Microbiol. Biotechnol. 2004, 64, 763–781.
25. Jaeger, K. E., Ransac, S., Dijkstra, B. W., Colson, C. et al., Bacterial lipases. FEMS Microbiol. Rev. 1994, 15, 29–63.
26. Čipinytė, V., Grigiškis, S., Baškys, E., Selection of fat-degrading microorganisms for the treatment of lipid-contaminated environment. Biologija 2009, 55, 84–92.
27. Gerard, P., Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 2013, 3, 14–24.
28. Duncan, S. H., Belenguer, A., Holtrop, G., Johnstone, A. M. et al., Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73, 1073–1078.
29. Daniel, H., Moghaddas Gholami, A., Berry, D., Desmarchelier, C. et al., High-fat diet alters gut microbiota physiology in mice. ISME J. 2014, 8, 295–308.
30. de Wit, N., Derrien, M., Bosch-Vermeulen, H., Oosterink, E. et al., Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G589–G599.
31. Devkota, S., Wang, Y., Musch, M. W., Leone, V. et al., Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012, 487, 104–108.
32. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A. et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470–1481.
33. Fava, F., Gitau, R., Griffin, B. A., Gibson, G. R. et al., The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population. Int. J. Obes. (Lond.) 2013, 37, 216–223.
34. Lam, Y. Y., Ha, C. W., Campbell, C. R., Mitchell, A. J. et al., Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012, 7, e34233.
35. Van der Meer, R., Lapré, J. A., Govers, M. J. A. P., Kleibeuker, J. H., Mechanisms of the intestinal effects of dietary fats and milk products on colon carcinogenesis. Cancer Lett. 1997, 114, 75–83.
36. Haghikia, A., Jorg, S., Duscha, A., Berg, J. et al., Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 2015, 43, 817–829.
37. Semova, I., Carten, J. D., Stombaugh, J., Mackey, L. C. et al., Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe 2012, 12, 277–288.
38. Cano, P. G., Santacruz, A., Moya, A., Sanz, Y., Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat- diet induced obesity. PLoS One 2012, 7, 1–16.
39. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761–1772.
40. Erridge, C., Attina, T., Spickett, C. M., Webb, D. J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 2007, 86, 1286–1292.
41. Samuel, V. T., Shulman, G. I., Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148, 852–871.
42. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P. et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U S A 2013, 110, 9066–9071.
43. Muccioli, G. G., Naslain, D., Backhed, F., Reigstad, C. S. et al., The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 2010, 6, 392.
44. Delzenne, N. M., Neyrinck, A. M., Backhed, F., Cani, P. D., Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 2011, 7, 639–646.
45. Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D. et al., Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab. 2015, 22, 658–668.
46. Yokota, A., Fukiya, S., Islam, K. B., Ooka, T. et al., Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes 2012, 3, 455–459.
47. Degirolamo, C., Modica, S., Palasciano, G., Moschetta, A., Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol. Med. 2011, 17, 564–572.
48. Trabelsi, M. S., Daoudi, M., Prawitt, J., Ducastel, S. et al., Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat. Commun. 2015, 6, 7629.
49. Vrieze, A., Out, C., Fuentes, S., Jonker, L. et al., Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatol. 2014, 60, 824–831.
50. Islam, K. B., Fukiya, S., Hagio, M., Fujii, N. et al., Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011, 141, 1773–1781.
51. Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K. et al., Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 2005, 589, 47–65.
52. Costabile, A., Klinder, A., Fava, F., Napolitano, A. et al., Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br. J. Nutr. 2008, 99, 110–120.
53. Duncan, S. H., Russell, W. R., Quartieri, A., Rossi, M. et al., Wheat bran promotes enrichment within the human colonic microbiota of butyrate-producing bacteria that release ferulic acid. Environ. Microbiol. 2015, 18, 2214–2225.
54. Lappi, J., Salojarvi, J., Kolehmainen, M., Mykkanen, H. et al., Intake of whole-grain and fiber-rich rye bread versus refined wheat bread does not differentiate intestinal microbiota composition in Finnish adults with metabolic syndrome. J. Nutr. 2013, 143, 648–655.
55. Martinez, I., Lattimer, J. M., Hubach, K. L., Case, J. A. et al., Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013, 7, 269–280.
56. Davis, L. M., Martinez, I., Walter, J., Goin, C. et al., Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 2011, 6, e25200.
57. Fernando, W. M., Hill, J. E., Zello, G. A., Tyler, R. T. et al., Diets supplemented with chickpea or its main oligosaccharide component raffinose modify faecal microbial composition in healthy adults. Benef. Microbes 2010, 1, 197–207.
58. Louis, P., Young, P., Holtrop, G., Flint, H. J., Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ. Microbiol. 2010, 12, 304–314.
59. Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A. et al., Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101, 541–550.
60. Garcia-Peris, P., Velasco, C., Lozano, M. A., Moreno, Y. et al., Effect of a mixture of inulin and fructo-oligosaccharide on Lactobacillus and Bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial. Nutr. Hosp. 2012, 27, 1908–1915.
61. Petry, N., Egli, I., Chassard, C., Lacroix, C. et al., Inulin modifies the bifidobacteria population, fecal lactate concentration, and fecal pH but does not influence iron absorption in women with low iron status. Am. J. Clin. Nutr. 2012, 96, 325–331.
62. Closa-Monasterolo, R., Gispert-Llaurado, M., Luque, V., Ferre, N. et al., Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial. Clin. Nutr. 2013, 32, 918–927.
63. Giovannini, M., Verduci, E., Gregori, D., Ballali, S. et al., Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: randomized multicenter trial. J. Am. Coll. Nutr. 2014, 33, 385–393.
64. Wernimont, S., Northington, R., Kullen, M. J., Yao, M. et al., Effect of an alpha-lactalbumin-enriched infant formula supplemented with oligofructose on fecal microbiota, stool characteristics, and hydration status: a randomized, double-blind, controlled trial. Clin. Pediatr. (Phila) 2015, 54, 359–370.
65. Majid, H. A., Cole, J., Emery, P. W., Whelan, K., Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial. Clin. Nutr. 2014, 33, 966–972.
66. Naughton, P. J., Mikkelsen, L. L., Jensen, B. B., Effects of nondigestible oligosaccharides on Salmonella enterica serovar Typhimurium and nonpathogenic Escherichia coli in the pig small intestine in vitro. Appl. Environ. Microbiol. 2001, 67, 3391–3395.
67. Holscher, H. D., Bauer, L. L., Gourineni, V., Pelkman, C. L. et al., Agave inulin supplementation affects the fecal microbiota of healthy adults participating in a randomized, double-blind, placebo-controlled, crossover trial. J. Nutr. 2015, 145, 2025–2032.
68. Vulevic, J., Juric, A., Tzortzis, G., Gibson, G. R., A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 2013, 143, 324–331.
69. Xiao, S., Fei, N., Pang, X., Shen, J. et al., A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol. Ecol. 2014, 87, 357–367.
70. Loh, G., Eberhard, M., Brunner, R. M., Hennig, U. et al., Inulin alters the intestinal microbiota and short-chain fatty acid concentrations in growing pigs regardless of their basal diet. J. Nutr. 2006, 136, 1198–1202.
71. Ze, X., Duncan, S. H., Louis, P., Flint, H. J., Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 2012, 6, 1535–1543.
72. Martinez, I., Kim, J., Duffy, P. R., Schlegel, V. L., Walter, J., Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 2010, 5, e15046.
73. Kovatcheva-Datchary, P., Egert, M., Maathuis, A., Rajilic-Stojanovic, M. et al., Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. Environ. Microbiol. 2009, 11, 914–926.
74. Dikeman, C. L., Fahey, G. C., Viscosity as related to dietary fiber: a review. Crit. Rev. Food. Sci. Nutr. 2006, 46, 649–663.
75. den Besten, G., van Eunen, K., Groen, A. K., Venema, K. et al., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013, 54, 2325–2340.
76. Pokusaeva, K., Fitzgerald, G. F., van Sinderen, D., Carbohydrate metabolism in Bifidobacteria. Genes Nutr. 2011, 6, 285–306.
77. Blaut, M., Gut microbiota and energy balance: role in obesity. Proc. Nutr. Soc. 2014, 74, 227–234.
78. Clausen, M. R., Mortensen, P. B., Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology 1994, 106, 423–432.
79. Demigne, C., Morand, C., Levrat, M. A., Besson, C. et al., Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br. J. Nutr. 1995, 74, 209–219.
80. Den Besten, G., Havinga, R., Bleeker, A., Rao, S. et al., The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome. PLoS One 2014, 9, e107392.
81. Lin, H. V., Frassetto, A., Kowalik, E. J., Jr., Nawrocki, A. R. et al., Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012, 7, e35240.
82. Wright, R. S., Anderson, J. W., Bridges, S. R., Propionate inhibits hepatocyte lipid synthesis. Proc. Soc. Exp. Biol. Med. 1990, 195, 26–29.
83. Sokol, H., Seksik, P., Furet, J. P., Firmesse, O. et al., Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15, 1183–1189.
84. Machiels, K., Joossens, M., Sabino, J., De Preter, V. et al., A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2013, 63, 1275–1283.
85. Takahashi, K., Nishida, A., Fujimoto, T., Fujii, M. et al., Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease. Digestion 2016, 93, 59–65.
86. Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y. et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58, 1091–1103.
87. Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S. et al., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27, 104–119.
88. Ploger, S., Stumpff, F., Penner, G. B., Schulzke, J. D. et al., Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann. N. Y. Acad. Sci. 2012, 1258, 52–59.
89. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A. et al., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504, 446–450.
90. Chang, P. V., Hao, L., Offermanns, S., Medzhitov, R., The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U S A 2014, 111, 2247–2252.
91. Mattace Raso, G., Simeoli, R., Russo, R., Iacono, A. et al., Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. PLoS One 2013, 8, e68626.
92. Liu, L., Li, L., Min, J., Wang, J. et al., Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol. 2012, 277, 66–73.
93. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E. et al., Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40, 128–139.
94. Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M. et al., The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003, 278, 11312–11319.
95. Kiefer, J., Beyer-Sehlmeyer, G., Pool-Zobel, B. L., Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. Br. J. Nutr. 2006, 96, 803–810.
96. Park, J., Kim, M., Kang, S. G., Jannasch, A. H. et al., Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015, 8, 80–93.
97. Khan, S., Jena, G. B., Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. Chem. Biol. Interact. 2014, 213, 1–12.
98. den Besten, G., Bleeker, A., Gerding, A., van Eunen, K. et al., Short-Chain Fatty Acids protect against High-Fat Diet-Induced Obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes 2015, 65, 2398–2408.
99. den Besten, G., Gerding, A., van Dijk, T. H., Ciapaite, J. et al., Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor gamma and glucagon-like peptide-1. PLoS One 2015, 10, e0136364.
100. Kuzmochka, C., Abdou, H. S., Hache, R. J., Atlas, E., Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the glucocorticoid-dependent CCAAT/enhancer-binding protein alpha (C/EBPalpha) expression and preadipocyte differentiation. Endocrinology 2014, 155, 4762–4773.
101. Davila, A. M., Blachier, F., Gotteland, M., Andriamihaja, M. et al., Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol. Res. 2013, 68, 95–107.
102. Smith, E. A., Macfarlane, G. T., Enumeration of amino acid fermenting bacteria in the human large intestine: effects of pH and starch on peptide metabolism and dissimilation of amino acids. FEMS Microbiol. Ecol. 1998, 25, 355–368.
103. Macfarlane, G. T., Cummings, J. H., in: Philips, S. F., Pemberton, J. H., Shorter, R. G. (Eds.), The Large Intestine. Physiology, Pathophysiology and Disease, Raven Press, New York 1991, pp. 51–92.
104. Jumas-Bilak, E., Carlier, J. P., Jean-Pierre, H., Mory, F. et al., Acidaminococcus intestini sp. nov., isolated from human clinical samples. Int. J. Syst. Evol. Microbiol. 2007, 57, 2314–2319.
105. Macfarlane, G. T., Protein degradation by human intestinal bacteria. J. Gen. Microbiol. 1986, 132, 1647–1656.
106. Cummings, J. H., The Large Intestine in Nutrition and Disease, Danone Institute, Brussels 1997, pp. 15–42.
107. Hamer, H. M., De Preter, V., Windey, K., Verbeke, K., Functional analysis of colonic bacterial metabolism: relevant to health? Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G1–G9.
108. Macfarlane, G. T., Macfarlane, S., Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Gastroenterol. Suppl. 1997, 222, 3–9.
109. Liu, X., Blouin, J. M., Santacruz, A., Lan, A. et al., High-protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: the increased luminal bulk connection. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 307, G459–G470.
110. Russell, W. R., Gratz, S. W., Duncan, S. H., Holtrop, G. et al., High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 2011, 93, 1062–1072.
111. Windey, K., De Preter, V., Verbeke, K., Relevance of protein fermentation to gut health. Mol. Nutr. Food Res. 2012, 56, 184–196.
112. Sridharan, G. V., Choi, K., Klemashevich, C., Wu, C. et al., Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat Commun. 2014, 5, 5492.
113. Kanehisa, M., Goto, S., Sato, Y., Kawashima, M. et al., Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014, 42, D199–D205.
114. Smith, E. A., Macfarlane, G. T., Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol. 1996, 81, 288–302.
115. Leidy, H. J., Clifton, P. M., Astrup, A., Wycherley, T. P. et al., The role of protein in weight loss and maintenance. Am. J. Clin. Nutr. 2015, 101(suppl), 1320S–1329S.
116. Santesso, N., Akl, E. A., Bianchi, M., Mente, A. et al., Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur. J. Clin. Nutr. 2012, 66, 780–788.
117. Wycherley, T. P., Moran, L. J., Clifton, P. M., Noakes, M. et al., Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2012, 96, 1281–1298.
118. Westerterp-Plantenga, M. S., Nieuwenhuizen, A., Tome, D., Soenen, S. et al., Dietary protein, weight loss, and weight maintenance. Ann. Rev. Nutr. 2009, 29, 21–41.
119. Chimerel, C., Emery, E., Summers, D. K., Keyser, U. et al., Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 2014, 9, 1202–1208.
120. Williams, B. B., Van Benschoten, A. H., Cimermancic, P., Donia, M. S. et al., Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 2014, 16, 495–503.
121. Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G. et al., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015, 161, 264–276.
122. Cryan, J. F., Dinan, T. G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13, 701–712.
123. Wall, R., Ross, R. P., Stanton, C., in: Lyte, M., Cryan, J. F. (Eds.), Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease, Springer, New York 2014.
124. Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A. et al., Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19, 576–585.
125. Hughes, R., Kurth, M. J., McGilligan, V., McGlynn, H. et al., Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro. Nutr. Cancer 2008, 60, 259–266.
126. Toden, S., Bird, A. R., Topping, D. L., Conlon, M. A., Resistant starch attenuates colonic DNA damage induced by higher dietary protein in rats. Nutr. Cancer 2005, 51, 45–51.
127. Toden, S., Bird, A. R., Topping, D. L., Conlon, M. A., Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats. Cancer Biol. Ther. 2006, 5, 267–272.
128. Toden, S., Belobrajdic, D. P., Bird, A. R., Topping, D. L. et al., Effects of dietary beef and chicken with and without high amylose maize starch on blood malondialdehyde, interleukins, IGF-I, insulin, leptin, MMP-2, and TIMP-2 concentrations in rats. Nutr. Cancer 2010, 62, 454–465.
129. Windey, K., De Preter, V., Louat, T., Schuit, F. et al., Modulation of protein fermentation does not affect fecal water toxicity: a randomized cross-over study in healthy subjects. PLoS One 2012, 7, e52387.
130. Salonen, A., Lahti, L., Salojarvi, J., Holtrop, G. et al., Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J. 2014, 8, 2218–2230.
131. Hildebrandt, M. A., Hoffmann, C., Sherrill-Mix, S. A., Keilbaugh, S. A. et al., High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137, 1716–1724; e1711–1712.
132. De La Serre, C. B., Ellis, C. L., Lee, J., Hartman, A. L. et al., Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299, G440–G448.
133. Lecomte, V., Kaakoush, N. O., Maloney, C. A., Raipuria, M. et al., Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One 2015, 10, e0126931.
134. Mujico, J. R., Baccan, G. C., Gheorghe, A., Diaz, L. E. et al., Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. Br. J. Nutr. 2013, 110, 711–720.
135. Mozes, S., Bujnakova, D., Sefcikova, Z., Kmet, V., Developmental changes of gut microflora and enzyme activity in rat pups exposed to fat-rich diet. Obesity (Silver Spring) 2008, 16, 2610–2615.
136. Carvalho-Wells, A. L., Helmolz, K., Nodet, C., Molzer, C. et al., Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study. Br. J. Nutr. 2010, 104, 1353–1356.
137. Marquez-Aguirre, A. L., Camacho-Ruiz, R. M., Arriaga-Alba, M., Padilla-Camberos, E. et al., Effects of Agave tequilana fructans with different degree of polymerization profiles on the body weight, blood lipids and count of fecal Lactobacilli/Bifidobacteria in obese mice. Food Funct. 2013, 4, 1237–1244.
138. Linetzky Waitzberg, D., Alves Pereira, C. C., Logullo, L., Manzoni Jacintho, T. et al., Microbiota benefits after inulin and partially hydrolized guar gum supplementation: a randomized clinical trial in constipated women. Nutr. Hosp. 2012, 27, 123–129.
139. Lecerf, J. M., Depeint, F., Clerc, E., Dugenet, Y. et al., Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br. J. Nutr. 2012, 108, 1847–1858.
140. Dewulf, E. M., Cani, P. D., Claus, S. P., Fuentes, S. et al., Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2012, 62, 1112–1121.
141. Benus, R. F., van der Werf, T. S., Welling, G. W., Judd, P. A. et al., Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br. J. Nutr. 2010, 104, 693–700.
142. Kleessen, B., Schwarz, S., Boehm, A., Fuhrmann, H. et al., Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br. J. Nutr. 2007, 98, 540–549.
143. Chung, W. S., Walker, A. W., Louis, P., Parkhill, J. et al., Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol. 2016, 14, 3.
144. Whisner, C. M., Martin, B. R., Schoterman, M. H., Nakatsu, C. H. et al., Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. Br. J. Nutr. 2013, 110, 1292–1303.